Skip to main content

Closed

IMMX: Immix Biopharma, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-42.3%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage0.0×

Current ratio8.76×

Immix Biopharma, Inc.

IMMXNASDAQ Capital Market·USD·Closed

Immix Biopharma, Inc.

IMMXNASDAQ·USD·Closed

$8.32

−2.69%

$8.32

−$0.23 (2.69%)

52W Range

63thpctl

Volume

0.90×avg

Mkt Cap

452.62MUSD

P/E

-9.0TTM

Div Yield

–ann

52W Range

63thpctl

Volume

0.90×avg

Market Cap

452.62MUSD

P/E Ratio

-9.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings